重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2014年
34期
4589-4590,4593
,共3页
冉燕%罗亚文%史军丽%赵建军%周凛梅
冉燕%囉亞文%史軍麗%趙建軍%週凜梅
염연%라아문%사군려%조건군%주름매
结核,肺%糖尿病%白细胞介素 2
結覈,肺%糖尿病%白細胞介素 2
결핵,폐%당뇨병%백세포개소 2
tuberculosis,pulmonary%diabetes mellitus%interleukin-2
目的:观察肺结核合并糖尿病患者血清 IL-2、TNF-α的表达,并初步探讨其临床意义。方法试验分为对照组(门诊健康体检者,n=10)、肺结核组(n=20)、糖尿病组(n=20)和肺结核合并糖尿病组(n=20),治疗2个月后根据病情转归将肺结核合并糖尿病组分为好转组及恶化组,ELISA法检测血清中 IL-2、TNF-α水平。结果治疗前:肺结核组、糖尿病组、肺结核合并糖尿病组血清 IL-2水平均降低(P<0.05),其中肺结核合并糖尿病组低于肺结核组和糖尿病组(P<0.05);肺结核合并糖尿病组、肺结核组、糖尿病组血清TNF-α水平均升高(P<0.05),其中肺结核合并糖尿病组高于糖尿病组(P<0.05);治疗后:肺结核合并糖尿病好转组血清 IL-2水平上升,而TNF-α水平有明显下降(P<0.05),恶化组治疗前后变化不明显(P>0.05)。结论IL-2、TNF-α在肺结核合并糖尿病的免疫发病机制中起着一定的作用,其动态变化能反应肺结核合并糖尿病的病情发展及转归。
目的:觀察肺結覈閤併糖尿病患者血清 IL-2、TNF-α的錶達,併初步探討其臨床意義。方法試驗分為對照組(門診健康體檢者,n=10)、肺結覈組(n=20)、糖尿病組(n=20)和肺結覈閤併糖尿病組(n=20),治療2箇月後根據病情轉歸將肺結覈閤併糖尿病組分為好轉組及噁化組,ELISA法檢測血清中 IL-2、TNF-α水平。結果治療前:肺結覈組、糖尿病組、肺結覈閤併糖尿病組血清 IL-2水平均降低(P<0.05),其中肺結覈閤併糖尿病組低于肺結覈組和糖尿病組(P<0.05);肺結覈閤併糖尿病組、肺結覈組、糖尿病組血清TNF-α水平均升高(P<0.05),其中肺結覈閤併糖尿病組高于糖尿病組(P<0.05);治療後:肺結覈閤併糖尿病好轉組血清 IL-2水平上升,而TNF-α水平有明顯下降(P<0.05),噁化組治療前後變化不明顯(P>0.05)。結論IL-2、TNF-α在肺結覈閤併糖尿病的免疫髮病機製中起著一定的作用,其動態變化能反應肺結覈閤併糖尿病的病情髮展及轉歸。
목적:관찰폐결핵합병당뇨병환자혈청 IL-2、TNF-α적표체,병초보탐토기림상의의。방법시험분위대조조(문진건강체검자,n=10)、폐결핵조(n=20)、당뇨병조(n=20)화폐결핵합병당뇨병조(n=20),치료2개월후근거병정전귀장폐결핵합병당뇨병조분위호전조급악화조,ELISA법검측혈청중 IL-2、TNF-α수평。결과치료전:폐결핵조、당뇨병조、폐결핵합병당뇨병조혈청 IL-2수평균강저(P<0.05),기중폐결핵합병당뇨병조저우폐결핵조화당뇨병조(P<0.05);폐결핵합병당뇨병조、폐결핵조、당뇨병조혈청TNF-α수평균승고(P<0.05),기중폐결핵합병당뇨병조고우당뇨병조(P<0.05);치료후:폐결핵합병당뇨병호전조혈청 IL-2수평상승,이TNF-α수평유명현하강(P<0.05),악화조치료전후변화불명현(P>0.05)。결론IL-2、TNF-α재폐결핵합병당뇨병적면역발병궤제중기착일정적작용,기동태변화능반응폐결핵합병당뇨병적병정발전급전귀。
Objective To investigate the expression of serum interleukin-2(IL-2),tumor necrosis factor-α(TNF-α)in the pa-tients with pulmonary tuberculosis and diabetes,and prelininary explore its clinical significance.Methods Experiment were divided into control group(health check-up outpatient,n=10),pulmonary tuberculosis group(n=20),diabetes group(n=20),tuberculosis combine diabetes group(n=20),tuberculosis combine diabetes group was divided into improved group,diabetes group and deterio-rated group after 2 months with therapy according to disease outcome,ELISA assay was used to measured the level of serum IL-2 and TNF-α.Results Before treatment:serum IL-2 levels of pulmonary tuberculosis group,diabetes group and pulmonary tuberculo-sis combine diabetes group were reduced (P<0.05),and the pulmonary tuberculosis group was lower than the pulmonary tubercu-losis group and diabetes group (P<0.05);serum TNF-αlevels of pulmonary tuberculosis combine diabetes group,pulmonary tu-berculosis group and diabetes group increased (P<0.05),and that of pulmonary tuberculosis combine diabetes group was higher than that of diabetes group (P<0.05).After treatment:the level of serum IL-2 increased and TNF-αsignificantly decreased in pul-monary tuberculosis combine diabetes improved group (P<0.05),the deterioration group had no change(P>0.05).Conclusion IL-2 and TNF-αplay a role in the immune pathogenesis of tuberculosis combine diabetes,which dynamic changes can reflect the progression and outcome of pulmonary tuberculosis combine diabetes.